Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types
N. Sinha, S. Sinha, C. V. Mayor, A. A. Schaffer, K. Aldape, K. Litchfield, T. Chan, L. G. T. Morris, E. Ruppin
The paper investigates how immune factors influence the predictive power of tumor mutational burden (TMB) for immunotherapy response across cancer types.
bioRxiv · May 25, 2021Cancer Biology